WSGR logoWSGR logo
Alex Dubose
Associate
Mergers & Acquisitions
New York

D212-515-8036

Download vCard
Open PDF

Alex Dubose is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses primarily on mergers and acquisitions. Alex advises both public and private companies, private equity funds, financial sponsors, and strategic investors in a variety of transactional matters, including mergers, carve-outs, acquisitions, divestitures, leveraged buyouts, stock purchases, asset acquisitions, tender offers, and other strategic corporate transactions.

Prior to joining the firm, Alex was an associate in the New York office of Latham & Watkins LLP.

Experience

Alex Dubose is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses primarily on mergers and acquisitions. Alex advises both public and private companies, private equity funds, financial sponsors, and strategic investors in a variety of transactional matters, including mergers, carve-outs, acquisitions, divestitures, leveraged buyouts, stock purchases, asset acquisitions, tender offers, and other strategic corporate transactions.

Prior to joining the firm, Alex was an associate in the New York office of Latham & Watkins LLP.

Focus Areas
Recent Insights
Client Highlights
Firm Advises Edgewise Therapeutics on Its Sale of Sevasemten for up to $2.65 Billion
On June 1, 2026, Edgewise Therapeutics, a leading muscle disease biopharmaceutical company, announced that it has entered into a definitive agreement under which Servier, an independent international pharmaceutical group governed by a foundation, will acquire sevasemten, an orally administered fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies, and Edgewise's muscular dystrophy business for $1.55 billion in upfront cash consideration and up to $1.1 billion in additional milestone payments, for aggregate potential consideration of up to $2.65 billion. The transaction strengthens Edgewise’s balance sheet, providing enhanced financial flexibility and sharpening the company’s strategic focus to accelerate and unlock the full potential of its cardiovascular pipeline. Wilson Sonsini Goodrich & Rosati advised Edgewise on the transaction.
Learn More
WSGR logo
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.